Review article: Genetic testing and counselling for hereditary colorectal cancer

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 11, 2002, Pages 1843-1857

  Trimbath, J D ^a   Giardiello, F M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER MORTALITY; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNITED STATES;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MUTATION;

EID: 0036828652     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01357.x     Document Type: Review

References (115)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society. 2002.
2. Burt RW, Petersen GM. Familial colorectal cancer: Diagnosis and management. In: Young. GP, Rozen. P, Levin. B, eds, Prevention and Early Detection of Colorectal Cancer, London: W.B. Saunders 1996; 171-94.
3. Giardiello FM. Gastrointestinal polyposis syndromes and hereditary nonpolyposis colorectal cancer. In: Rustgi A, ed. Gastrointestinal Cancers: Biology, Diagnosis, and Therapy, New York: Ravin Press 1995.
4. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997; 336: 823-7.
5. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
6. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-5.
7. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
8. Wermstrom J, Pierce ER, McKusick VA. Hereditary benign and malignant lesions of the large bowel. Cancer 1974; 34: 850.
9. Bussey HJR, Familial polyposis coli. Family Studies, Histopathology. Differential Diagnosis, and Results of Treatment, Baltimore. MD: Johns Hopkins University Press. 1975.
10. Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1990; 100: 1658-64.
11. Jarvinen HJ. Time and type of prophylactic surgery for familial adenomatous coli. Ann Surg 1985; 202: 93-7.
12. Spigelman AD, Phillips RKS. The upper gastrointestinal tract. In: Phillips RKS, Spigelman AD, Thomson JPS, eds. Familial Adenomatous Polyposis and Other Polyposis Syndromes, London: Edward Arnold. 1994.
13. Offerhaus GJA, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992; 102: 1980-2.
14. Leppard BJ. Epidermoid cysts, polyposis coli. Pro R Soc Med 1974; 67: 1036-7.
15. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumors in familial adenomatous polyposis. Gut 1993; 35: 377-81.
16. Gardner EJ. Follow-up study of a group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas, and epidermal cysts. Am J Hum Genet 1962; 14: 376-90.
17. Giardiello FM, Offerhaus GJA, Traboulsi EI, et al. The value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut 1991; 32: 1170-4.
18. Sondergaard JO, Bulow S, Jarvinen H, Wolf J, Witt IN, Teten G. Dental anomalies in familial adenomatous polyposis coli. Acta Odont Scand 1987; 45: 61-3.
19. Traboulsi EI, Murphy S, Dela Cruz ZC, Maumenee IH, Green WR. A clinicopathological study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner syndrome). Am J Ophthalmol 1990; 110: 550-61.
20. Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology 1993; 105: 1550-2.
21. Giardiello FM, Offerhaus GJA, Krush AJ, et al. The risk of hepatoblastoma in familial adenomatous polyposis, J Pediatrics 1991; 119: 766-8.
22. Giardiello FM, Offerhaus GJA, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34: 1394-6.
23. Hamilton SR, Liu B, Parsons RD, et al. The molecular basis of Turcot syndrome. N Engl J Med 1995: 332: 839-47.
24. Laken SJ, Papadopoulos N, Petersen G, et al. Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA 1999; 96: 2322-6.
25. Kinzler KW, Vogelstein B, Colorectal tumors. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis of Human Cancer. New York: McGraw-Hill. 1998; 565-90.
26. Laurent-Puig P, Beroud C, Soussi T. APC gene: Database of germline and somatic mutations in human tumors and cell lines. Nucl Acids Res 1998; 26: 269-70.
27. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: An attenuated form of familial polyposis. Cell 1993; 75: 951-7.
28. Giardiello FM. Brensinger JD. Luce MC, et al. Phenotypic expression in adenomatous polyposis families with mutation in the 5′ region of the adenomatous polyposis coli gene. Ann Intern Med 1997; 126: 514-9.
29. Brensinger JD, Laken SJ, Luce MC, et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutations in the APC gene. Gut 1998; 43: 548-52.
30. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Askenazim due to a hypermutable tract in APC. Nature Genet 1997; 17: 79-83.
31. Nagase H, Miyoshi Y, Horii A, et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992; 52: 4055-7.
32. Giardiello FM, Petersen GM, Piantadosi S, et al. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 1997; 40: 521-5.
33. Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57: 1151-8.
34. Giardiello FM, Krush AJ, Petersen GM, et al. Phenotypic variablity of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106: 1542-7.
35. Yah H, Dobbie Z, Gruber SB, et al. Small changes in expression affect predisposition to tumorigenesis. Nat Genet 2002; 30: 25-6.
36. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening and surveillance. Clinical guidelines, evidence, and rationale. Gastroenterology 1997; 112: 594-642.
37. Cromwell DM, Moore RD, Brensinger JD, Petersen GM, Bass EB, Giardiello FM. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis. Gastroenterology 1998; 114: 893-901.
38. Giardiello FM, Petersen GM, Brensinger JD, et al. Hepatoblastoma and APC gene mutation in familial adenomatous. Gut 1996; 39; 867-9.
39. Romans K, Hylind LM, Booker SV, et al. Hereditary Colorectal Cancer Website, www.Hopkins-coloncancer.org.2000.
40. Lynch HT, Smyrk T, McGinn T, et al. Attenuated familial adenomatous polyposis (AFAP): A phenotypically and genotypically distinctive variant of FAP. Cancer 1995; 76: 2427-33.
41. Burt RW, Kuwada SK, Kerber R, Slattery M, DiSario JA, White R. The predominance of proximal colonic neoplasms in attenuated adenomatous polyposis coli. Gastroenterology 1995; 108: A453 (Abstract).
42. Rozen P, Shomrat R, Strul H, et al. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 1999; 11: 54-7.
43. Tomlinson I, Rahman N, Frayling L, et al. Inherited susceptibility to colorectal adenomas and carcinomas. Evidence lbr for a new predispostion gene on 15q14-q22. Gastroenterology 1999; 116: 789-95.
44. Houlston RS, Tomlinson IPM. Polymorphisms and colorectal tumor risk. Gastroenterology 2001; 121: 282-301.
45. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in two large midwestern kindreds. Arch Intern Med 1966; 117: 206-12.
46. Vasen HFA, Nagengast FM, Meera Khan P. Interval cancer in hereditary non-polyposis colorectal cancer (Lynch syndrome) Lancet 1995; 345: 1183-4.
47. Boland CR. Hereditary nonpolyposis colorectal cancer. In: The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998; 333-46.
48. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review. Gastroenterology 1993; 104: 1535-49.
49. Rodriquez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 1758-62.
50. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
51. Vasen HFA, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-7.
52. Lynch HT, Smyrk TC. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): Updated Rev Cancer 1996; 78: 1149-67.
53. Smyrk TC, Lynch HT, Watson PA, Appelman HD. Histologic features of hereditary nonpolyposis colorectal carcinoma, In: Utsunomiya, J, Lynch, HT, eds. Hereditary Colorectal Cancer. Tokyo: Springer-Verlag, 1990; 357-62.
54. Forster S, Sattler H-P, Hack M, et al. Microsatellite instability in sporadic carcinomas of the proximal colon: Association with diploid DNA content, negative protein expression of p53 and distinct histomorphologic features. Surgery 1998; 123: 13-8.
55. Gryfe R. Kim H, Hsieh ETK, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342: 69-7.
56. Vasen HFA, Offerhaus GJA, den Hartog Jager FCA, Menko FH, Nagengast FM, et al, The tumour spectrum in hereditary non-polyposis colorectal cancer: A study of 24 kindreds in The Netherlands. Int J Cancer 1990; 46: 31-4.
57. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71: 677-85.
58. Watson P, Vasen HFA, Mecklin J-P, et al. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994; 96: 516-20.
59. Aarnio M, Mecklin J-P, Aaltonen LA. Lifetime risk of different cancers in hereditary nonpolyposis colorectal cancer. Int J Cancer 1995; 64: 430-3.
60. Brensinger JD, Petersen GM, Erdman SH. et al. Café au lait spots and early on set colorectal neoplasia: A variant of HNPCC. Gastroenterology 1999; 116: A382(Abstract).
61. Vasen HFA, Mecklin JP, Meera Khan P, Lynch HT. The International Collaborative Group on Hereditary non-polyposis colorectal cancer. Dis Colon Rect 1991; 34: 424-5.
62. Vasen HFA, Watson P, Mecklin JP, Lynch HT. the ICGHNPCC. New criteria for hereditary non-polyposis colorectal cancer (HNPCC. Lynch syndrome) proposed by the International Collaborative Group on HNPCC (ICG-HNPCC). Gastroenterology 1999; 116: 453-6.
63. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog hMSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-38.
64. Leach FS, Nicolaides N, Papadopoulos N, et al. Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 1993; 75: 1215-25.
65. Papadopoulos N. Nicolaides NC, Wei Y-F, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 16252-9.
66. Bronner CE, Baker SM, Morrison PT, et al. Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994: 368: 258-61.
67. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80.
68. Akiyama Y, Sato H, Yamada T, et al. Germ-line mutations of hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1997; 57: 3920-3.
69. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of the hMSH6 gene as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17: 271-2.
70. Liu B, Parson R, Papadopoulous N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2: 169-74.
71. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993: 260: 812-6.
72. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. A National Cancer institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57.
73. American Gastroenterological Association. American Gastroenterological Association medical position statement: Hereditary colorectal cancer genetic testing. Gastroenterology 2001; 121; 195-7.
74. Hailing KC, French AJ, McDonnell SK. et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999; 91: 1295-303.
75. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B. Association of Lumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000; 355: 1745-50.
76. NCCN colorectal cancer screening practice guidelines. Natl Comp Cancer Network Oncol 1999; 13: 152-79.
77. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. J Am Med Assoc 1997; 277: 915-9.
78. Fitzgibbons RJ, Lynch HT, Lanspa SJ, et al. Surgical strategies for management of the Lynch syndromes. In: Utsunomiya, J. Lynch, H. eds. Hereditary Colorectal Cancer. New York: Springer-Verlag, 1990; 211-7.
79. Lynch HT, Lynch J. Natural history, molecular genetics, genetic counseling, surveillance, and management of HNPCC. J Tumor Marker Oncol 1995; 10: 7-31.
80. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121: 198-213.
81. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 1996; 14: 1730-40.
82. Holtzman NA. Promoting safe and effective genetic testing in the United States: Work of the task force on genetic testing. Clin Chem 1999; 45: 732-8.
83. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk. J Am Med Assoc 1994; 271: 785.
84. Petersen GM, Brensinger JD, Johnson KA, Giardiello FM. Genetic testing and counseling for hereditary forms of colorectal cancer. Cancer 1999; 86(11 Suppl.): 2540-50.
85. Geller G, Botkin JR, Green MJ, et al. Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. J Am Med Assoc 1997; 277: 1467-74.
86. Petersen GM, Brensinger JD. Genetic testing and counseling in familial adenomatous polyposis. Oncology 1996: 10: 89-94.
87. Miyoshi Y, Ando H, Nagase H, et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 1992; 89: 4452-6.
88. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-7.
89. MacDonald F, Morton DG, Rindl PM, et al. Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: Population based study. Br Med J 1992; 4: 869-72.
90. Giardiello F. Genetic testing in hereditary colorectal cancer. J Am Med Assoc 1997; 278: 1278-81.
91. O'Reilly S, Johnson KA, Brensinger JD, Giardiello FM. Hereditary nonpolyposis colorectal cancer. Ann Oncol 1997; 8: 1151-6.
92. Halford S, Sasieni P, Rowan A, et al. Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res 2002; 62: 53-7.
93. Planck M, Koul A, Fernebro E, et al. hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden, Int J Cancer 1999; 83: 197-202.
94. Wang Q, Lasset C, Desseigne F, et al. Prevalence of germline mutations of hMLHI, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet 1999; 105: 79-85.
95. Park JG, Park YJ, Wijnen JT, Vasen HF. Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implication for diagnosis and genetic testing. Int J Cancer 1999; 82: 516-9.
96. Aaltonen LA, Peltomaki P, Mecklin JP, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients, Cancer Res 1994; 54: 1645-8.
97. Brassett C, Joyce JA, Froggatt NJ, et al. Microsatellite instability in early onset and familial colorectal cancer. J Med Genet 1996; 33: 981-5.
98. Calistri D, Presciuttini S, Buonsanti G, et al. Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition. Int J Cancer 2000; 89: 87-91.
99. Muta H, Noguchi M, Perucho M, et al. Clinical implications off microsatellite instability in colorectal cancers. Cancer 1996; 15: 265-70.
100. Fujiwara T, Stolker JM, Watanabe T, et al, Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 1998; 153: 1063-78.
101. Senba S, Konishi F, Okamoto T, et al. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors, Cancer 1998; 82: 279-85,
102. Ishimaru G, Adacchi J, Shiseki M, Yamaguchi N, Muto T, Yokota J. Microsatellite instability in primary and metastatic colorectal cancers, Int J Cancer 1995; 64: 153-7.
103. Bubb VJ, Curtis Q, Cunningham C, et al. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer, Oncogene 1996; 12: 2641-9.
104. Kim H, Piao Z, Kim JW, et al. Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol Res Pract 1998; 194: 3-9.
105. Liu B, Farrington SM, Petersen GM. et al, Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995; 1: 348-52,
106. Cawkwell L, Gray S, Murgatroyd H, et al. Choice of management strategy for colorectal cancer based on a diagnositic immunohistochemistry test for defective mismatch repair, Gut 1999; 45: 409-15.
107. Cunningham JM, Kim CY, Tester DJ, et al. The frequency and mechanism of defective DNA mismatch repair in unselected colorectal carcinomas, Proc Am Assoc Cancer Res 1999; 40: 1611 (Abstract).
108. Weber TK, Conlon W, Petrelli NJ, et al. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees, Cancer Res 1997; 57: 3798-803.
109. Syngal S, Fox EA, Li C, et al. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing, J Am Med Assoc 1999; 282: 247-53.
110. Buerstedde JM, Alday P, Torhorst J, Weber W, Muller H, Scott R. Detection of new mutations in six out of ten Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes. J Med Genet 1995; 32: 909-12.
111. Moslem G, Tester DJ, Lindor NM, et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 1996; 5: 1245-52.
112. Luce MC, Marra G, Chauhan DP, et al. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995; 109: 1368-74.
113. Nystrom-Lahti M, Wu Y, Moisio AL, et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary nonpolyposis colorectal cancer, Hum Mol Genet 1996; 5: 763-9.
114. Farrington SM, Lin-Goerke J, Ling J, et al. Systematic analysis of hMSH2 and hLMH1 in young colon cancer patients and controls. Am J Hum Genet 1998; 63: 749-59.
115. Wijnen JT, Vasen HFA, Khan M, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. New Engl J Med 1998; 339: 511-8.